Results 231 to 240 of about 3,419,452 (348)

Equiatomic Transition Metal Alloys of Manganese. II. The Tetragonal IrMn Phase. [PDF]

open access: bronze, 1965
Kari Brun   +5 more
openalex   +1 more source

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

open access: yesMolecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho   +11 more
wiley   +1 more source

Phase transition in Bi8Fe6Ti3O27 multiferroic ceramics

open access: yesOpen Physics, 2008
Patri Sunanda, Choudhary Ram
doaj   +1 more source

Hand Milling Induced Phase Transition for Marcasite-type Carbodiimide. [PDF]

open access: yesJ Am Chem Soc
Yamamoto Y   +11 more
europepmc   +1 more source

Equiatomic Transition Metal Alloys of Manganese. III. The Tetragonal NiMn Phase. [PDF]

open access: bronze, 1965
W. B. Pearson   +5 more
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

open access: yesMolecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski   +19 more
wiley   +1 more source

Photonic topological phase transition induced by material phase transition. [PDF]

open access: yesSci Adv
Uemura T   +7 more
europepmc   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

open access: yesMolecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy